{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:37:08Z","timestamp":1782290228585,"version":"3.54.5"},"reference-count":65,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,20]]},"DOI":"10.18632\/oncotarget.5857","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"32439-32455","source":"Crossref","is-referenced-by-count":33,"title":["Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-\u03baB crosstalk"],"prefix":"10.18632","volume":"6","author":[{"given":"Menaka C.","family":"Thounaojam","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duafalia F.","family":"Dudimah","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Samuel T.","family":"Pellom","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA"},{"name":"Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, TN, USA"},{"name":"School of Graduate Studies and Research, Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman V.","family":"Uzhachenko","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Carbone","sequence":"additional","affiliation":[{"name":"Department of Medicine, James Cancer Center, The Ohio State University, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail M.","family":"Dikov","sequence":"additional","affiliation":[{"name":"Department of Medicine, James Cancer Center, The Ohio State University, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shanker","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA"},{"name":"School of Graduate Studies and Research, Meharry Medical College, Nashville, TN, USA"},{"name":"Host-Tumor Interactions Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri2488","article-title":"The different faces of Notch in T-helper-cell differentiation","volume":"9","author":"Flavell","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0092-8674(04)00451-9","article-title":"Instruction of distinct CD4 T helper cell fates by different Notch ligands on antigen-presenting cells","volume":"117","author":"Flavell","year":"2004","journal-title":"Cell"},{"key":"3","first-page":"115","article-title":"The role of Notch in the differentiation of CD4(+) T helper cells","volume":"360","author":"Tacchini-Cottier","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri3445","article-title":"Regulation of innate and adaptive immunity by Notch","volume":"13","author":"Tacchini-Cottier","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.immuni.2006.04.009","article-title":"The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells","volume":"24","author":"Kubo","year":"2006","journal-title":"Immunity"},{"key":"6","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.1300369","article-title":"Involvement of Notch in activation and effector functions of gammadelta T cells","volume":"192","author":"Chiplunkar","year":"2014","journal-title":"J Immunol"},{"key":"7","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1401671111","article-title":"Differentiation of CD11c+CX3CR1+ cells in the small intestine requires Notch signaling","volume":"111","author":"Yasutomo","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1535-6108(03)00137-5","article-title":"Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis","volume":"3","author":"Capobianco","year":"2003","journal-title":"Cancer Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3892\/ijo_32_6_1335","article-title":"Down-regulation of Notch-1 expression decreases PU. 1-mediated myeloid differentiation signaling in acute myeloid leukemia","volume":"32","author":"Yang","year":"2008","journal-title":"Int J Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Sklar","year":"1991","journal-title":"Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood.V96.5.1906","article-title":"A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice","volume":"96","author":"Cleary","year":"2000","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11010-010-0394-9","article-title":"Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein","volume":"340","author":"Han","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10428190109064603","article-title":"Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells","volume":"42","author":"Nara","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Aster","year":"2004","journal-title":"Science"},{"key":"15","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Pear","year":"2006","journal-title":"Genes Dev"},{"key":"16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.devcel.2009.03.010","article-title":"Notch signaling: the core pathway and its posttranslational regulation","volume":"16","author":"Fortini","year":"2009","journal-title":"Dev Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Ilagan","year":"2009","journal-title":"Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1083\/jcb.200811141","article-title":"A Notch updated","volume":"184","author":"Bellen","year":"2009","journal-title":"J Cell Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.emboj.7600902","article-title":"Notch1 augments NF-kappaB activity by facilitating its nuclear retention","volume":"25","author":"Osborne","year":"2006","journal-title":"EMBO J"},{"key":"20","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/emboj\/18.10.2803","article-title":"Rel\/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors","volume":"18","author":"Gelinas","year":"1999","journal-title":"EMBO J"},{"key":"21","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1084\/jem.183.5.2025","article-title":"T cell leukemia-associated human Notch\/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells","volume":"183","author":"Hoffman","year":"1996","journal-title":"J Exp Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4049\/jimmunol.167.1.289","article-title":"Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain","volume":"167","author":"Guan","year":"2001","journal-title":"J Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1074-7613(00)00009-1","article-title":"Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes","volume":"13","author":"Bevan","year":"2000","journal-title":"Immunity"},{"key":"24","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.4049\/jimmunol.165.9.5004","article-title":"NF-kappa B is required for the positive selection of CD8+ thymocytes","volume":"165","author":"Leiden","year":"2000","journal-title":"J Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ccr.2010.08.006","article-title":"The Notch\/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia","volume":"18","author":"Mullighan","year":"2010","journal-title":"Cancer Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1158\/0008-5472.CAN-10-4366","article-title":"Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth","volume":"71","author":"Carbone","year":"2011","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Rahman","year":"2004","journal-title":"Clin Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Pazdur","year":"2007","journal-title":"Clin Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1182\/blood-2010-07-294983","article-title":"Efficacy and safety of once-weekly bortezomib in multiple myeloma patients","volume":"116","author":"Musto","year":"2010","journal-title":"Blood"},{"key":"30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cncr.23606","article-title":"Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network","volume":"113","author":"Greco","year":"2008","journal-title":"Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05188.x","article-title":"A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0609.2009.01385.x","article-title":"Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA","volume":"84","author":"Bringhen","year":"2010","journal-title":"Eur J Haematol"},{"key":"33","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Hideshima","year":"2003","journal-title":"N Engl J Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood-2006-08-036947","article-title":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial","volume":"110","author":"Alsina","year":"2007","journal-title":"Blood"},{"key":"35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jnci\/djn113","article-title":"Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody","volume":"100","author":"Sayers","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1158\/1541-7786.MCR-10-0022","article-title":"Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex","volume":"8","author":"Sayers","year":"2010","journal-title":"Mol Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2567.2007.02761.x","article-title":"Proteasome inhibition suppresses essential immune functions of human CD4+ T cells","volume":"124","author":"Naujokat","year":"2008","journal-title":"Immunology"},{"key":"38","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.leukres.2011.05.018","article-title":"Depletion of alloreactive T-cellsusing the proteasome inhibitor bortezomib preserves the immune response against pathogens","volume":"35","author":"Perez-Simon","year":"2011","journal-title":"Leuk Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","article-title":"Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study","volume":"26","author":"Richardson","year":"2008","journal-title":"J Clin Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.4049\/jimmunol.1103826","article-title":"Immune mechanism of the antitumor effects generated by bortezomib","volume":"189","author":"Hung","year":"2012","journal-title":"J Immunol"},{"issue":"10","key":"41","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.167.10.5994","article-title":"Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection","volume":"167","author":"Perkins","year":"2001","journal-title":"J Immunol"},{"key":"42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3816\/CLML.2010.n.019","article-title":"Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib","volume":"10","author":"Sezer","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminhematol.2012.04.004","article-title":"Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience","volume":"49","author":"Nencioni","year":"2012","journal-title":"Semin Hematol"},{"key":"44","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-07-4744","article-title":"Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma","volume":"14","author":"Salih","year":"2008","journal-title":"Clin Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.160.2.643","article-title":"Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity","volume":"160","author":"Sherman","year":"1998","journal-title":"J Immunol"},{"key":"46","first-page":"238","article-title":"Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1recombinant adenovirus","volume":"3","author":"Carbone","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Massague","year":"2005","journal-title":"Cancer Cell"},{"key":"48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1146\/annurev.immunol.23.021704.115747","article-title":"Regulation of lymphoid development, differentiation, and function by the Notch pathway","volume":"23","author":"Pear","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nri1998","article-title":"Notch signalling during peripheral T-cell activation and differentiation","volume":"7","author":"Minter","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1045","article-title":"Notch regulation of lymphocyte development and function","volume":"5","author":"MacDonald","year":"2004","journal-title":"Nat Immunol"},{"key":"51","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.4049\/jimmunol.0802598","article-title":"Notch regulates cytolytic effector function in CD8+ T cells","volume":"182","author":"Osborne","year":"2009","journal-title":"J Immunol"},{"key":"52","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood-2012-07-442962","article-title":"Notch controls generation and function of human effector CD8+ T cells","volume":"121","author":"Unger","year":"2013","journal-title":"Blood"},{"key":"53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11523-010-0165-2","article-title":"Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy","volume":"5","author":"Dechowdhury","year":"2010","journal-title":"Target Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"Anderson","year":"2009","journal-title":"Blood"},{"key":"55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood-2009-07-235663","article-title":"Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma","volume":"116","author":"Furukawa","year":"2010","journal-title":"Blood"},{"key":"56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2002-09-2975","article-title":"The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP","volume":"102","author":"Murphy","year":"2003","journal-title":"Blood"},{"key":"57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.immuni.2009.04.017","article-title":"Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy","volume":"31","author":"Lai","year":"2009","journal-title":"Immunity"},{"key":"58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/1074-7613(94)90063-9","article-title":"Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules","volume":"1","author":"Henkart","year":"1994","journal-title":"Immunity"},{"key":"59","doi-asserted-by":"crossref","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Karlsson","year":"2014","journal-title":"PLoS Pathog"},{"key":"60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.1099962","article-title":"Oscillations in NF-kappaB signaling control the dynamics of gene expression","volume":"306","author":"Benson","year":"2004","journal-title":"Science"},{"key":"61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives","volume":"11","author":"Dou","year":"2011","journal-title":"Current Cancer Drug Targets"},{"key":"62","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.1103102","article-title":"Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli","volume":"189","author":"Dallman","year":"2012","journal-title":"J Immunol"},{"key":"63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/cdd.2009.20","article-title":"A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells","volume":"16","author":"Sarin","year":"2009","journal-title":"Cell Death Differ"},{"key":"64","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00018-010-0391-x","article-title":"Non-canonical activation of Notch signaling\/target genes in vertebrates","volume":"67","author":"James","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbadis.2008.06.008","article-title":"Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes","volume":"1782","author":"Screpanti","year":"2008","journal-title":"Biochim Biophys Acta"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:39:40Z","timestamp":1692038380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":65,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015,10,20]]}},"alternative-id":["5857","26431276"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5857","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}